Literature DB >> 17923467

Relationship of epicardial adipose tissue by echocardiography to coronary artery disease.

S-G Ahn1, H-S Lim, D-Y Joe, S-J Kang, B-J Choi, S-Y Choi, M-H Yoon, G-S Hwang, S-J Tahk, J-H Shin.   

Abstract

OBJECTIVE: To study the relationship of echocardiographic epicardial adipose tissue (EAT) with coronary artery disease (CAD) risk factors and the extent of coronary atherosclerosis.
METHODS: EAT thickness was measured in 527 patients undergoing their first coronary angiography. EAT was defined as an echo-lucent area on the free wall of the right ventricle on the still image of the two-dimensional echocardiogram at end diastole in the parasternal long-axis and parasternal short-axis views. A CT scan at the umbilicus was acquired to measure abdominal visceral adipose tissue (VAT) from a random sample of 30 patients. The extent of coronary atherosclerosis was assessed using a coronary atherosclerosis score based on the quantitative coronary angiography results.
RESULTS: EAT thickness was correlated with abdominal VAT (r(s) = 0.626, p<0.001), age (r(s) = 0.480, p<0.001), waist circumference (r(s) = 0.309, p<0.001), body mass index (r(s) = 0.233, p<0.001), C reactive protein (r(s) = 0.224, p<0.001), and the homoeostasis model assessment score (r(s) = 0.249, p<0.001). EAT was thicker in subjects with CAD than in those without CAD (4.0 vs 1.5 mm, p<0.001). Patients with unstable angina had thicker EAT than those with stable angina or atypical chest pain (4.0, 3.0, and 1.5 mm, respectively, p<0.001). EAT (> or =3.0 mm) was an independent factor of CAD on multiple logistic analysis (odds ratio = 3.357; 95% CI 2.177 to 5.175, p<0.001).
CONCLUSIONS: These results suggest that EAT may reflect the amount of visceral fat, which is associated with insulin resistance and inflammation. The echocardiographic measurement of EAT may provide additional information for assessing CAD risk and predicting the extent and activity of CAD.

Entities:  

Mesh:

Year:  2008        PMID: 17923467     DOI: 10.1136/hrt.2007.118471

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  97 in total

1.  Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography.

Authors:  Hikmet Yorgun; Uğur Canpolat; Tuncay Hazırolan; Hamza Sunman; Ahmet Hakan Ateş; Kadri Murat Gürses; Ozgür Ertuğrul; Ergün Barış Kaya; Kudret Aytemir; Lale Tokgözoğlu; Giray Kabakçı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-03       Impact factor: 2.357

2.  3D-Dixon MRI based volumetry of peri- and epicardial fat.

Authors:  Rami Homsi; Michael Meier-Schroers; Jürgen Gieseke; Darius Dabir; Julian A Luetkens; Daniel L Kuetting; Claas P Naehle; Christian Marx; Hans H Schild; Daniel K Thomas; Alois M Sprinkart
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-30       Impact factor: 2.357

3.  Evaluation of the relationship between epicardial fat volume and left ventricular diastolic dysfunction.

Authors:  Murat Vural; Aslı Talu; Deniz Sahin; Ozgul Ucar Elalmis; Hasan Ali Durmaz; Sadık Uyanık; Betul Akdal Dolek
Journal:  Jpn J Radiol       Date:  2014-04-01       Impact factor: 2.374

4.  Relationship between epicardial adipose tissue thickness and early impairment of left ventricular systolic function in patients with preserved ejection fraction.

Authors:  Keiko Watanabe; Tomonori Kishino; Junko Sano; Toshiyuki Ariga; Shuhei Okuyama; Hideaki Mori; Satsuki Matsushima; Kouki Ohtsuka; Hiroaki Ohnishi; Takashi Watanabe
Journal:  Heart Vessels       Date:  2015-02-27       Impact factor: 2.037

5.  Carotid intima-media thickness and epicardial fat thickness predict precoronary artery disease status in psoriasis.

Authors:  Banavasi Shanmukha Girisha; Shajahan Shibina; U Raghuraja; K Subramanyam
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

6.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

7.  Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study.

Authors:  Haim Shmilovich; Damini Dey; Victor Y Cheng; Ronak Rajani; Ryo Nakazato; Yuka Otaki; Rine Nakanishi; Piotr J Slomka; Louise E J Thomson; Sean W Hayes; John D Friedman; Heidi Gransar; Nathan D Wong; Leslee J Shaw; Matthew Budoff; Alan Rozanski; Daniel S Berman
Journal:  Am J Cardiol       Date:  2011-08-30       Impact factor: 2.778

8.  Is the measurement of epicardial fat in obese adolescents valuable?

Authors:  Joon-Han Shin
Journal:  Korean Circ J       Date:  2012-07-26       Impact factor: 3.243

9.  Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: findings from the CTRAD study.

Authors:  Dilbahar S Mohar; Jonathan Salcedo; Khiet C Hoang; Shivesh Kumar; Farhood Saremi; Ashwini S Erande; Nassim Naderi; Pradeep Nadeswaran; Christine Le; Shaista Malik
Journal:  Diabetes Res Clin Pract       Date:  2014-09-06       Impact factor: 5.602

Review 10.  Epicardial and thoracic fat - Noninvasive measurement and clinical implications.

Authors:  Damini Dey; Ryo Nakazato; Debiao Li; Daniel S Berman
Journal:  Cardiovasc Diagn Ther       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.